Anti-Cancer Agents in Medicinal Chemistry
Title: Editorial [Hot Topic:Preamble: CDC25 Phosphatases in Cancer and CDC25 Inhibitors (Guest Editor: Gregoire Pierre Prevost)]
Volume: 8 Issue: 8
Author(s): Gregoire Pierre Prevost
Affiliation:
Export Options
About this article
Cite this article as:
Prevost Pierre Gregoire, Editorial [Hot Topic:Preamble: CDC25 Phosphatases in Cancer and CDC25 Inhibitors (Guest Editor: Gregoire Pierre Prevost)], Anti-Cancer Agents in Medicinal Chemistry 2008; 8 (8) . https://dx.doi.org/10.2174/187152008786847774
DOI https://dx.doi.org/10.2174/187152008786847774 |
Print ISSN 1871-5206 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5992 |
15
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Synthetic 2-Methoxyestradiol Derivatives: Structure-Activity Relationships
Current Medicinal Chemistry microRNAs as Anti-Cancer Therapy
Current Pharmaceutical Design Aminocoumarins: A Privileged Precursor for the Synthesis of Fused Heterocycles
Current Organic Chemistry Compound Ranking Based on a New Mathematical Measure of Effectiveness Using Time Course Data from Cell-Based Assays
Combinatorial Chemistry & High Throughput Screening Preface
Clinical Cancer Drugs Biodistribution and Pharmacokinetics of I-131 Labelled 4- Iodophenylacetic Acid
Current Radiopharmaceuticals Targeted Therapy Options for Treatment of Bone Metastases; Beyond Bisphosphonates
Current Pharmaceutical Design Structural Characterization, Homology Modeling and Docking Studies of ARG674 Mutation in MyH8 Gene Associated with Trismus-Pseudocamptodactyly Syndrome
Letters in Drug Design & Discovery Overcoming the Blood-Brain Barrier for Chemotherapy: Limitations, Challenges and Rising Problems
Anti-Cancer Agents in Medicinal Chemistry Recent Development of CB2 Selective and Peripheral CB1/CB2 Cannabinoid Receptor Ligands
Current Medicinal Chemistry Dietary Supplement Use in Patients with Rheumatoid Arthritis in Japan
Current Rheumatology Reviews Zinc Dependent Histone Deacetylase Inhibitors in Cancer Therapeutics: Recent Update
Current Medicinal Chemistry Antitumor Potential of Marine Natural Products: A Mechanistic Investigation
Anti-Cancer Agents in Medicinal Chemistry Therapeutic Modulation of Gut Microbiota: Current Clinical Applications and Future Perspectives
Current Drug Targets RNA Interference-Mediated Validation of Survivin and Apollon/BRUCE as New Therapeutic Targets for Cancer Therapy
Current Topics in Medicinal Chemistry Vaccines and Other Immunological Approaches for Cancer Immunoprevention
Current Drug Targets Communicating HIV Results to Low-Risk Individuals: Still Hazy After All These Years
Current HIV Research Synthesis and In Vitro Biochemical Evaluation of a Series of Alkyl 6- Aminosulfonyl Naphthanoates as Potential Inhibitors of Human Placental Estrone Sulfatase (ES)
Letters in Drug Design & Discovery The Functions of Histone Modification Enzymes in Cancer
Current Protein & Peptide Science Hepatocarcinogenesis and Ceramide/Cholesterol Metabolism
Anti-Cancer Agents in Medicinal Chemistry